The keywords of the inquiry, both as text and MeSH terms variously combined, were “Lu-PSMA”, “177Lu PSMA”, “preclinical”, “mouse”, “salivary gland cancer”, “breast cancer” “glioblastoma” “solid tumour”, “renal cell carcinoma”, “HCC”, “thyroid”, “salivary”, “radioligand therapy” and “luthetium-177”. Here, FOLH1 is linked to breast carcinoma.